To continue delivering high-quality, timely care, the McGill University Health Centre (MUHC) has selected GrayOS to optimize the planning and scheduling of systemic therapy treatments at the Cedars Cancer Centre.

The MUHC is one of North America’s largest and most modern academic health networks. Its Research Institute is Quebec’s leading research hospital and has ranked among Canada’s top three research hospitals for five consecutive years. 

The MUHC’s Cedars Cancer Centre delivers care to over 1,100 newly diagnosed cancer patients who require chemotherapy each year. It also delivers nearly 21,000 chemotherapy treatments annually. Like many leading cancer centers, the Cedars Cancer Centre faces growing patient volumes and increasingly complex treatment pathways within a context of limited resources.

The deployment of GrayOS introduces automation and algorithmic scheduling to help the MUHC better coordinate daily operations, anticipate bottlenecks, and make the best use of available capacity. By reducing manual planning and improving visibility across the care pathway, the initiative will free up staff time for patient-facing activities.

“Thanks to this innovative project, we hope to be able to treat more patients, faster, using the same resources,” says Dr. Lucie Opatrny, President and Executive Director, MUHC. “This is a great example of how artificial intelligence can help us improve efficiency while maintaining the highest standards of care. It also means that nurses who previously spent time scheduling will be able to dedicate more time to being at the bedside, where they are most needed.”

“We’re honoured to collaborate with the MUHC, an institution recognized for its clinical and scientific excellence,” said André Diamant, CEO of Gray Oncology Solutions, who also completed his PhD research at the MUHC. “This collaboration is particularly meaningful to me. Together, we share the same ambition : to put technology at the service of people and make care delivery more seamless, efficient, and sustainable.”

Through this collaboration, the MUHC aims to strengthen its operational resilience and further expand access to timely cancer treatment ; outcomes that matter deeply when every day counts in oncology care.

This new deployment reinforces the growing adoption of GrayOS across North America. From academic hospitals to regional cancer centers, more institutions are turning to care orchestration to simplify operations, protect staff well-being, and improve access to timely treatment.